guide 9 min read

Growth Hormone Peptides: Sermorelin, Ipamorelin & CJC-1295

Understanding growth hormone secretagogues, how they stimulate natural HGH production, and their benefits for aging and recovery.

Growth hormone secretagogues (GHS) are peptides that stimulate the pituitary gland to produce and release more human growth hormone (HGH). Unlike synthetic HGH injections, these peptides work with your body's natural feedback mechanisms.

Sermorelin is a synthetic version of Growth Hormone-Releasing Hormone (GHRH). It mimics the first 29 amino acids of natural GHRH and is well-studied with decades of clinical use. It is particularly effective for improving sleep quality and supporting overall recovery.

Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin levels. This selectivity makes it one of the safest GHS options, with fewer side effects than alternatives.

CJC-1295 is a modified GHRH analog that provides sustained GH elevation due to its longer half-life. It is often paired with Ipamorelin for synergistic effects, creating a combination that is frequently referred to as the gold standard for GH optimization.

Benefits of GH peptides include improved body composition, enhanced recovery from exercise, better sleep quality, healthier skin and hair, and improved cognitive function. Most users notice improvements within 4-8 weeks of consistent use.

These peptides are typically administered via subcutaneous injection before bedtime to align with the body's natural GH release patterns. Cycles of 8-12 weeks are common, with periodic breaks to maintain pituitary sensitivity.

Referenced Studies

1

Endocrine and Metabolic Effects of Long-Term Administration of [Nle27]Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women

Khorram O, Laughlin GA, Yen SSC · Journal of Clinical Endocrinology & Metabolism (1997)

Key Finding: Sermorelin analog significantly increased nocturnal GH levels in both women and men, with improvements in lean body mass and insulin sensitivity.

2

Ipamorelin, the First Selective Growth Hormone Secretagogue

Raun K, Hansen BS, Johansen NL, et al. · European Journal of Endocrinology (1998)

Key Finding: Ipamorelin did not increase ACTH or cortisol even at doses 200-fold above the ED50 for GH release, making it the first truly selective GH secretagogue.

3

Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults

Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA · Journal of Clinical Endocrinology & Metabolism (2006)

Key Finding: A single CJC-1295 injection produced dose-dependent GH increases of 2- to 10-fold lasting 6+ days, and IGF-I increases of 1.5- to 3-fold for 9-11 days.